Salon: How a debate over two competing vaccines gripped the medical community — in 1961
Polio vaccine developed by UC's Albert Sabin embraced by world, then U.S. 60 years ago
When a polio epidemic swept across the globe for much of the 20th century, a pair of researchers raced to develop a vaccine to halt the disabling virus that could lead to paralysis.
Salon.com is out with an in-depth feature story about the efforts of Albert Sabin, a University of Cincinnati researcher, and Jonas Salk, a University of Pittsburgh scientist. Both are credited with incredible breakthroughs that ultimately led to eliminating the virus in most of the world. According to the Centers for Disease Control, no cases have originated in the United States since 1979.
According to the Salon article, "the U.S. felt that Salk's vaccine had solved the polio problem and there was no need for another vaccine. So, Sabin turned to other countries for support.
"In the Soviet Union, millions of people participated in a clinical trial. With its success established, the Soviet Union began manufacturing Sabin's vaccine. It is remarkable that at the height of the Cold War an American polio vaccine got its first foothold in the communist world. Eventually, Sabin's vaccine would be approved for use in the United States in 1961 and, in a victory for Sabin, replaced Salk's vaccine in 1962."
Read the complete article
Featured image at top: Albert Sabin, MD, administers the live oral polio vaccine to children.
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Follow all of UC's advanced related to the COVID-19 vaccine, or schedule a virtual visit to UC and begin picturing yourself at an institution that inspires incredible breakthroughs.
Related Stories
UC welcomes Microsoft to the 1819 Innovation Hub
December 6, 2024
Microsoft has joined the 1819 Innovation Hub at the University of Cincinnati, as reported by the Cincinnati Business Courier.
Physicists outline next 10 years of neutrino research
December 6, 2024
News media highlight a paper co-written by UC physicists that outlines the next 10 years of research into some of the tiniest known particles. Upcoming experiments could unlock secrets to the origins of the universe.
Is it time to worry about benzene?
December 6, 2024
The University of Cincinnati's Kelly Dobos was featured in a New York Times article discussing the latest knowledge on the effects of the carcinogen benzene in personal care products.